Pluristem Therapeutics Inc (PSTI)

[skitahoe]

I believe that if an Analyst were being honest, he might say $15 is a target for the company on initiating trials for coronavirus, but a multibillion dollar market cap should result from an approval. When it reaches $15 he can revise upward, but many analysts will move a stock to a hold rating when their target price is reached. If the stock goes to $150 they'll take credit for the gain, they said hold, not sell, even though they gave you new stocks they rated buys.

I hate analysts who don't look at the long term potential.

Gary